RIGL
Rigel Pharmaceuticals Inc
Price:  
1.55 
USD
Volume:  
1,342,081.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RIGL Relative Valuation

-317.4%
Upside

As of 2024-03-03, the Relative Valuation of Rigel Pharmaceuticals Inc (RIGL) is (3.37) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.55 USD, the upside of Rigel Pharmaceuticals Inc based on Relative Valuation is -317.4%.

The range of the Relative Valuation is (3.14) - (3.75) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 22.4x - 27.3x 24.8x
Forward P/E multiples 19.7x - 26.8x 23.2x
Fair Price (3.14) - (3.75) (3.37)
Upside -302.5% - -342.2% -317.4%
1.55 USD
Stock Price
(3.37) USD
Fair Price

RIGL Relative Valuation - Historical P/E Data

Date P/E
2024-03-01 -11.06
2024-02-29 -10.85
2024-02-28 -11.06
2024-02-27 -10.71
2024-02-26 -10.14
2024-02-23 -9.42
2024-02-22 -9.28
2024-02-21 -7.99
2024-02-20 -8.14
2024-02-16 -8.35
2024-02-15 -8.71
2024-02-14 -8.42
2024-02-13 -7.99
2024-02-12 -8.64
2024-02-09 -8.57
2024-02-08 -8.14
2024-02-07 -7.99
2024-02-06 -8.71
2024-02-05 -8.35
2024-02-02 -8.14
2024-02-01 -8.57
2024-01-31 -8.35
2024-01-30 -8.92
2024-01-29 -9.28
2024-01-26 -9.21
2024-01-25 -8.92
2024-01-24 -8.74
2024-01-23 -9.06
2024-01-22 -9.21
2024-01-19 -9.71
2024-01-18 -9.56
2024-01-17 -9.64
2024-01-16 -9.71
2024-01-12 -9.49
2024-01-11 -9.56
2024-01-10 -9.71
2024-01-09 -9.78
2024-01-08 -10.56
2024-01-05 -9.85
2024-01-04 -10.63
2024-01-03 -10.35
2024-01-02 -10.42
2023-12-29 -10.35
2023-12-28 -11.13
2023-12-27 -10.49
2023-12-26 -10.06
2023-12-22 -9.99
2023-12-21 -8.99
2023-12-20 -8.78
2023-12-19 -8.78